Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Porter Derrell. Insider active across 1 company, notably Acumen Pharmaceuticals, Inc.. In total, 7 reports have been logged. Breakdown: 0 buy · 3 sells. History available since 4 June 2025. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Porter Derrell is a declarant linked to Acumen Pharmaceuticals, Inc. (XNAS), where he is a director. The record includes 6 filings, and the sampled recent filings run from 2026-06-05 to 2026-06-17, with reported buy and sell volumes of 0 EUR and a dominant transaction nature of sale.